Recent studies identified somatic mutations of JAK3 in a minority of acute megakaryoblastic leukemia patients [7-10], in a high-risk childhood acute lymphoblastic leukemia (ALL) case [11], and in cutaneous T-cell lymphoma patients [12]. The gene discussed is JAK3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.